Pet Pharm Biotech Co (ROCO:7762) Interest Expense: NT$-0.9 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7762 Pet Pharm Biotech Co Ltd ROCO:7762
17 GF Score
Price NT$50.90
! 5 Warning Signs
View Full Analysis

What is Pet Pharm Biotech Co Interest Expense?

Pet Pharm Biotech Co ROCO:7762 +1.39% 17 Interest Expense is NT$-0.9 Mil as of Dec. 2025. GuruFocus rates ROCO:7762 with a GF Score™ of 17/100. The stock has 5 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Pet Pharm Biotech Co's interest expense for the six months ended in Dec. 2025 was NT$ -0.8 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-0.9 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Pet Pharm Biotech Co's Operating Income for the six months ended in Dec. 2025 was NT$ 11.7 Mil. Pet Pharm Biotech Co's Interest Expense for the six months ended in Dec. 2025 was NT$ -0.8 Mil. Pet Pharm Biotech Co's Interest Coverage for the quarter that ended in Dec. 2025 was 15.43. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Pet Pharm Biotech Co  (ROCO:7762) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Pet Pharm Biotech Co's Interest Expense for the six months ended in Dec. 2025 was NT$-0.8 Mil. Its Operating Income for the six months ended in Dec. 2025 was NT$11.7 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2025 was NT$94.6 Mil.

Pet Pharm Biotech Co's Interest Coverage for the quarter that ended in Dec. 2025 is calculated as

Interest Coverage=-1* Operating Income (Q: Dec. 2025 )/Interest Expense (Q: Dec. 2025 )
=-1*11.652/-0.755
=15.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Pet Pharm Biotech Co Interest Expense Historical Data

* Premium members only.

The historical data trend for Pet Pharm Biotech Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pet Pharm Biotech Co Interest Expense Chart

Pet Pharm Biotech Co Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Interest Expense
-0.20 -0.18 -0.18 -0.89

Pet Pharm Biotech Co Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Interest Expense Get a 7-Day Free Trial -0.10 -0.10 -0.08 -0.14 -0.76
ROCO:7762
17GF Score
Pet Pharm Biotech Co Ltd ROCO:7762
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pet Pharm Biotech Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-0.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of NT$-0.9 Mil mean?
Pet Pharm Biotech Co (ROCO:7762) has a Interest Expense of NT$-0.9 Mil as of Dec. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on Pet Pharm Biotech Co and its competitors.
Is Pet Pharm Biotech Co's Interest Expense too high?
Pet Pharm Biotech Co's current Interest Expense is NT$-0.9 Mil. Overall, Pet Pharm Biotech Co has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Pet Pharm Biotech Co's Interest Expense compare to LLY and JNJ?
Pet Pharm Biotech Co's Interest Expense of NT$-0.9 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Drug Manufacturers company?
A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Pet Pharm Biotech Co and its competitors. Pet Pharm Biotech Co's current Interest Expense is NT$-0.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pet Pharm Biotech Co stock overvalued right now?
Pet Pharm Biotech Co (ROCO:7762) has a current Interest Expense of NT$-0.9 Mil. The current Interest Expense is NT$-0.9 Mil. Pet Pharm Biotech Co's overall GF Score™ is 17/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Pet Pharm Biotech Co (ROCO:7762), the current Interest Expense is NT$-0.9 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pet Pharm Biotech Co Business Description

Address 143, Hougang 1st Road, 1-2F., No. 141, Xinzhuang District, New Taipei City, TWN, 242051
Pet Pharm Biotech Co Ltd is a Pharmaceutical company. The company is engaged in manufacturing medicinal products and medicine drugs. The products offered by the company include FDG Fluodeoxyglucose Injection (18F-FDG), Naolixi Injection (18F-FBB), Sodium fluoride injection (18F-NaF), and others.
17GF Score

Get the complete analysis for ROCO:7762

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$50.90
Price